Answers are grounded in this paper and cite their sources.
In the era of increasing antimicrobial resistance and diminishing antibiotic pipeline, the use of antibiotic adjuvants that decrease the excessive use of antibiotics while preserving the efficacy holds considerable promise. In this study, we report the design of cationic 23-residue proamyloidogenic peptides with no antimicrobial properties that can sensitize Gram-negative bacteria to antibiotics. In experimental model, peptides-antibiotic (half-dose) combination significantly decreases the bacterial burden and disease severity in comparison to monotherapies. We show that the peptides agglutinate bacteria cells and form amyloid fibrils by interacting with the outer membrane components, facilitating the antibiotic uptake. The peptides self-assemble only in the presence of lipopolysaccharide (LPS) and do not form similar structures in the presence of negatively charged liposomes/micelles. Nuclear magnetic resonance (NMR) and cryo-electron microscopy (Cryo-EM) are used to study the peptides-lipopolysaccharide complex structure. The proposed approach offers a promising strategy that can potentiate the antibiotic activity of existing antibiotics and minimize excessive use of antibiotics, expanding the antibiotic armamentarium.
No takes yet. Share an insight, caveat, or question.
Mohid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: